- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02574624
Vitreous Surgery With Intraocular Assistance (VISIA)
September 25, 2017 updated by: Peter A Campochiaro, MD, Johns Hopkins University
Vitreous Surgery With Intraocular Assistance (VISIA)
To Assess the Safety of Vitreous surgery with intraocular assistance (VISIA) & to identify and document with video evidence and surgeon's case report forms intraocular maneuvers that are facilitated by VISIA.
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Detailed Description
Standard care surgery will be done with a few novel additions to facilitate the surgical procedure.
Currently 3 ports are inserted by creating holes in the sclera (white part of the eye) to enter into the posterior part of the eye.
When complex dissection is needed, a fourth port will be inserted.
The assistant will insert light source through the 4th port.
This eliminates the need for the surgeon to hold the light in one hand.
Hence allows freeing of both hands for the surgeon to use a forceps in one hand to grasp and elevate membranes and a scissors in the other to cut connections between the retina and the membranes.
When membranes are particularly thick, it can be difficult to dissect with a single forceps holding up the membrane.
In this situation, a 5th port will be inserted allowing the assistant to insert a light source through one and a forceps though another.
The surgeon will have a forceps in one hand and a scissors in another making dissection process more efficient.
Study Type
Interventional
Enrollment (Actual)
5
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21287
- Wilmer Eye Institute, Johns Hopkins University School of Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 100 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
All subjects must meet the following criteria to be eligible for study entry:
- Signed informed consent and authorization of use and disclosure of protected health information
- Age ≥18 years
- Subject will have complex retinal pathology for which it is judged that surgical objectives could be facilitated by VISIA
Exclusion Criteria:
Subjects who meet any of the following criteria will be ineligible for study entry:
• Patients with disease processes such as macular pucker and macular hole that are generally well-managed by standard two-handed vitrectomy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Intraocular Assistance
Intraocular assistance in patients undergoing standard of care vitreous surgeries
|
Intraocular assistance with help of surgical assistants during vitreous surgery (VISIA) in patients who require vitreous surgeries as part of standard of care procedure for conditions like retinal detachments, dislocated intraocular lens and glaucoma patients requiring endophotocoagulation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
The primary outcome measure is recording of adverse events directly related to VISIA and adverse events unrelated to VISIA.
Time Frame: 4 months
|
4 months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Surgeon's assessment of the benefits and risks of VISIA recorded on the surgical case report form.
Time Frame: 4 months
|
4 months
|
Assistant's assessment of the benefits and risks of VISIA recorded on the surgical case report form.
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Peter A. Campochiaro, MD, Johns Hopkins University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 1, 2015
Primary Completion (Actual)
September 1, 2017
Study Completion (Actual)
September 1, 2017
Study Registration Dates
First Submitted
September 24, 2015
First Submitted That Met QC Criteria
October 9, 2015
First Posted (Estimate)
October 14, 2015
Study Record Updates
Last Update Posted (Actual)
September 26, 2017
Last Update Submitted That Met QC Criteria
September 25, 2017
Last Verified
September 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VISIA
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dislocated Intraocular Lens
-
St. Erik Eye HospitalUmeå UniversityCompleted
-
Omer Othman AbdullahCompleted
-
Peregrine Eye and Laser InstituteAlcon ResearchRecruitingVitreous Hemorrhage | Retinal Detachment | Epiretinal Membrane | Vitrectomy | Macular Holes | Dislocated Intraocular Lens Into Vitreous | Retained Lens FragmentsPhilippines
-
University Hospital AugsburgRecruitingIntraocular Lens Rotation | Lens Opacities | Intraocular Lens Associated Postoperative Inflammation | Intraocular Lens ComplicationGermany
-
Medical University of ViennaCompleted
-
Faculty Hospital Kralovske VinohradySomich, s.r.o.; Očni centrum Praha a.s.Recruiting
-
Taipei Nobel Eye ClinicCompleted
-
Faculty Hospital Kralovske VinohradyRecruitingIntraocular LensCzechia, Slovakia
-
Aier School of Ophthalmology, Central South UniversityUnknown
-
Medicontur Medical Engineering LtdActive, not recruitingCataract | Pseudophakia | Intraocular Lens Complication | Intraocular Lens OpacificationHungary
Clinical Trials on Intraocular assistance
-
Ewha Womans UniversityCompletedOsteoarthritisKorea, Republic of
-
Swiss Federal Institute of TechnologyCompletedMuscle Weakness | Muscular Dystrophies | Muscular Dystrophy | Muscular Dystrophy, Facioscapulohumeral | Scapular Dyskinesis | Muscular WeaknessGermany, Switzerland
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Recruiting
-
Case Western Reserve UniversityCompletedSmoking Cessation | Food InsecurityUnited States
-
University of OklahomaUnited States Department of Agriculture (USDA)CompletedHealth Behavior | Nutrition PoorUnited States
-
VA Office of Research and DevelopmentNot yet recruiting
-
Karolinska University HospitalKarolinska Institutet; Medical University of Vienna; Stockholm School of EconomicsEnrolling by invitation
-
NYU Langone HealthCompletedStroke | Post-Stroke HemiparesisUnited States
-
Renmin Hospital of Wuhan UniversityUnknown
-
Renmin Hospital of Wuhan UniversityUnknownAdenoma Detection RateChina